# AZD8683 Multiple Dose Study in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients

> **NCT01584739** · PHASE1 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 30 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** AZD8683
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01584739
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01584739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01584739, "AZD8683 Multiple Dose Study in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT01584739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*